Get Rid of Double Chin with Kybella

Kybella In the News – Portland, Oregon

Kybella is an injectable formulation specially designed to correct the change in appearance caused by double chin. Double chin generally develops as a result of the accumulation of fat tissue in the sub mental region. It is a product of KYTHERA Biopharmaceuticals, Inc. that is FDA approved and has been credited as a major breakthrough in the field of cosmetic medicine.

Kybella is a cytolytic drug and its active ingredient is deoxycholic acid. It is a fully non-invasive procedure and is the only FDA approved non-surgical method available for the treatment of unwanted submental fat. The release of Kybella was meticulously tested by numerous clinical trials to verify its safety and efficacy before its release.

The drug is injected into the submental fat, each injection using 0.2 mL of the drug. Up to 50 injections can be administered in a single setting. One setting generally lasts for 15-20 minutes. The amount of drug that is to be administered is tuned to be 2 mg/cm2.

It will administered only by Dr. Rajani to improve the cosmetic appearance of a person caused by double chin. This ensures minimal tissue damage and reduces the risk of development of side effects. To minimize the risk of nerve damage, it has been advised to inject Kybella close to the salivary glands, lymph nodes and muscles. The fat tissue between the dermis and platysma must be identified first to avoid injecting the drug into the platysma. The area into which the drug is to be injected must be marked beforehand so as to avoid injecting outside the defined limits. A large barrel syringe is used for the purpose of injecting the drug (air bubbles must be expelled).

In certain instances (infections, for instance), Kybella is fully contraindicated for use. The patient must be cautiously selected for the procedure. Other causes of fat under the chin should always be ruled out before using Kybella. For example, thyroid gland enlargement, cervical lymphadenopathy, or other conditions could cause a double chin. The limitation being faced currently is that it cannot be used for any other area of the body.

Side effects of Kybella were also seen during the clinical trials.
These include:
• Asymmetric smile or facial muscle weakness due to nerve damage
• Dysphagia
• Local pain, swelling, erythema etc.
• Injection site hematoma/bruising
• Skin ulceration

Further trials are being held to improve Kybella so that its benefits can reach across the globe.